Drugs@FDA: FDA-Approved Drugs

Home | Previous Page

New Drug Application (NDA): 206545
Company: GILEAD SCIENCES INC

• REMS

• Summary Review

Products on NDA 206545

Drug Name	Active Ingredients	Strength	Dosage Form/Route	Marketing Status	TE Code	RLD	RS
ZYDELIG	IDELALISIB	100MG	TABLET;ORAL	Prescription	TBD	TBD	No
ZYDELIG	IDELALISIB	150MG	TABLET;ORAL	Prescription	TBD	TBD	No

Approval Date(s) and History, Letters, Labels, Reviews for NDA 206545

Original Approvals or Tentative Approvals

Action Date	Submission	Action Type	Submission Classification	Review Priority; Orphan Status	Letters, Reviews, Labels, Patient Package Insert	Notes	Url
07/23/2014	ORIG-1	Approval		PRIORITY; Orphan	Label (PDF) Letter (PDF) Review Summary Review (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2014/206545lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2014/206545Orig1s000ltr.pdf https://www.accessdata.fda.gov/drugsatfda_docs/nda/2014/206545Orig1s000TOC.cfm https://www.accessdata.fda.gov/drugsatfda_docs/nda/2014/206545Orig1s000SumR.pdf

Labels for NDA 206545

Action Date	Submission	Supplement Categories or Approval Type	Letters, Reviews, Labels, Patient Package Insert	Note	Url
07/23/2014	ORIG-1	Approval	Label (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2014/206545lbl.pdf

Therapeutic Equivalents for NDA 206545

ZYDELIG

There are no Therapeutic Equivalents.